openPR Logo
Press release

Chronic Disease Management Services Market Growth, Demand and Key Players to 2017-2027

02-08-2018 10:38 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Future Market Insights

Chronic Disease Management Services Market Growth, Demand

Chronic disease management services are also referred as enhance primary care. This service is provided to the patient suffering from the chronic or terminal health condition and require multidisciplinary care. If any patient suffering from the chronic medical condition such as asthma, COPD, cancer, diabetes, stroke or musculoskeletal diseases for more than six months. However, there is no specified condition for the patient to provide chronic disease management service. Chronic disease management services are generally provided are long-term care center and rehabilitation center. In chronic care management services patient are aware of the more reliable treatment option. Patient thoroughly guided with to choose appropriate physician and treatment to cure the disease. This improves the quality of care of patient through various means. Chronic disease management services provider also aware the patient with the available reimbursement scenario provided by Medicare and Medicaid and also guide them to claim the respective allowances. If the patients are opting for chronic disease management service, there is strong possibility that patient will get most appropriate treatment with cheaper price and also get the benefit of allocated reimbursement.

Chronic Disease Management Services Market: Drivers and Restraints

Increasing prevalence of chronic diseases such as asthma, COPD, cancer, diabetes, stroke or musculoskeletal diseases around the globe is the major factor driving the growth of chronic diseases management services market. Beside that increasing awareness of regarding the healthcare management service have also upsurge the growth of chronic disease management services market over the forecast period. Moreover, improved services by service provider have increased the demand for chronic disease management services in the market. The growth in the medical tourism sector and rise in healthcare IT solution have fueled the progression of chronic disease management service market. Inadequate patient engagement and lack of interoperability may responsible for the sluggish growth of this market. Besides that high investment required to establish the infrastructure and data security concerns related to cloud-based solutions can also hamper the progress of chronic disease management services market.

Request Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5370

Chronic Disease Management Services Market: Segmentation

The global chronic disease management services market is classified on the basis delivery mode, end user, geographic region.

Based on service type, chronic disease management services market is segmented into following:

Consulting service
Implementation Service
Educational Services
Other

Based on delivery mode, chronic disease management services market is segmented into following:

On Premise
Web based
Cloud based

Based on end user, chronic disease management services market is segmented into following:

Provider
Payer

Chronic Disease Management Services Market: Overview

The chronic diseases management services market is expected show significant growth over the forecast period due to increasing awareness of people. In 2010 overall spending on chronic diseases management services is 73.6 million. Approximately 36 million people have taken the advantage of Medicare reimbursement policy in 2015 due chronic disease management services. There is huge competition among the leading services provider in this market. Both leading and local service provider offers various scheme to compete in the market. Chronic disease management service is taking gaining the attractiveness throughout the globe, due to the use of health information technologies and improved availability of the online resource in the healthcare. Leading services providers of this market are focusing on the collaboration and partnership with healthcare stakeholders to provide patient-centric care.

Visit For TOC@ https://www.futuremarketinsights.com/toc/rep-gb-5370

Chronic Disease Management Services Market: Regional Overview

Based on geographic region Chronic Disease Management Services market is classified into seven key regions, North, America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, Middle East and Africa. North America is expected to be the most attractive market for chronic disease management service due to the availability of high healthcare infrastructure. This market is then followed by Western Europe and Eastern Europe owing to rising awareness of people in this region. APEJ and Japan are expected to be fastest growing market owing to increasing geriatric population. MEA and Latin America is expected to be the least attractive region for chronic disease management services market due to inadequate patient engagement.

Chronic Disease Management Services Market: Key Players

Examples of some of the market participants in chronic disease management services market identified across the value chain include, TriZetto Corporation, Phytel Inc., Pegasystems Inc. EXL Healthcare, AxisPoint Health, Wellcentive, Inc, Medecision, Inc, i2i Systems, Inc., HealthSmart Holdings, Inc., Allscripts Healthcare Solutions, Inc. ZeOmega Inc. Epic Corporation Inc, and Harmony Information Systems, Inc.

About Us –

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Disease Management Services Market Growth, Demand and Key Players to 2017-2027 here

News-ID: 936592 • Views:

More Releases from Future Market Insights

Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Million by 2032
Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Milli …
The lithium-ion battery separator is a critical component in lithium-ion batteries, responsible for preventing short circuits and ensuring safe and efficient battery performance. It acts as a physical barrier between the positive and negative electrodes, allowing lithium ions to pass through while blocking the flow of electrons. With advancements in separator technology, these separators play a key role in enhancing battery capacity, cycle life, and overall safety in various applications,
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolstered by a Robust 7.1% CAGR from 2022
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolst …
The Industrial Drums Market is experiencing a steady and promising trajectory, with an estimated value of US$ 12.5 billion in 2022, projected to escalate to US$ 17.6 billion by 2027 at a commendable Compound Annual Growth Rate (CAGR) of 7.1%. This growth is substantiated by a 6.6% CAGR in volume during 2022-27, as per Future Market Insights. Anticipated to expand 1.5 times within this period, the market presents alluring prospects for industry
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of the Metal Cans Industry, Catering to Health-conscious and Environmentally-aware Consumers
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of …
The metal cans market is predicted to grow at a CAGR of 5% over the forecast period, according to research by Future Market Insights. The industry's estimated value is expected to increase from US$ 56 Bn in 2023 to US$ 91.1 Bn by 2033. The market for metal cans has been driven by the heightened demand for the product in food and beverages industry. Metal cans helps prolong shelf-life of perishable
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 with a 4.8% CAGR
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 …
The folding intermediate bulk containers (IBCs) market is on a growth trajectory, with an estimated value of US$ 418 million in 2022, projected to reach US$ 528 million by 2027, showcasing a Compound Annual Growth Rate (CAGR) of 4.8%. Remarkably, the China folding IBCs market defied initial pandemic-related skepticism and is anticipated to grow by 6.9% year on year in 2022. Despite global challenges, China's folding IBCs market is poised to contribute

All 5 Releases


More Releases for Chronic

Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Reviewed, …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017”, provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney Disease (Chronic Renal Failure). Report includes an overview of trial numbers and
Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Market Res …
Latest industry research report on: Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, T …
Orbisreserach.Com Adds “H1 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Market Pipeline Review 2017 Trend Analysis Report Report” To Its Research Database Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2017, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) pipeline landscape. Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in the blood-forming cells of the
Boot chronic pain
For immediate release Due to our rushed lives and stressful environment, many people are suffering from chronic pain and fatigue. We feel permanently tired and are barely able to get through our normal day. One is able to change this status when following the guidelines the book "Tired of being Tired to the point of being Gatvol (Fed Up). Some people will need a team of medical practitioners to help them
11-10-2016 | Health & Medicine
MRR.biz
Global Chronic, Acute, And Neuropathic Pain Market: Opioids To Remain Most Value …
The research report, titled “Frontier Pharma: Chronic, Acute And Neuropathic Pain - GPCR And Nerve Growth Factor-Based Therapies Offer Strong Potential In Difficult-To-Treat Subtypes,” analyzes the historical as well as the existing performance of this market, emphasizing specifically on various types of therapies applied to treat chronic, acute, and neuropathic pain. According to this 68-page study, the worldwide market for chronic, acute, and neuropathic pain has been observing a significant
Targeting chronic pain
With the support of the Austrian Science Fund FWF, the neurophysiologist Ruth Drdla-Schutting is investigating the role astrocytes play in the genesis of chronic pain. With the help of innovative gene technology (DREADDs), scientists are tailoring treatment specifically to these cells that are the most numerous found in the central nervous system. Pain is an important protection system of the human body. But when it becomes chronic, as it frequently